nadifloxacin
This page covers all nadifloxacin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.
Phase 3 pipeline (1)
- Nadixa · Infectious Disease
Nadixa works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication and transcription.
Patent intelligence
- nadifloxacin patent landscape — aggregated cliff calendar, attackable patents, originator estates